Home » Topics » Disease categories and therapies » Urology

Urology
RSS

FDA approves Procysbi for children aged 2-6 years with nephropathic cystinosis

Aug. 18, 2015

First patients randomized in phase IIa trial of SER-150 in diabetic nephropathy

Aug. 17, 2015

Proteon initiates second phase III study of vonapanitase

Aug. 17, 2015

Daiichi Sankyo discloses compounds for hyperphosphatemia

Aug. 13, 2015

Relypsa signs new patiromer agreements

Aug. 12, 2015

FDA accepts NDA for ZS-9 in hyperkalemia

July 30, 2015

Phase III extension studies show long-term benefit of NX-1207 in BPH

July 29, 2015

EMA committee recommends approval of Fexeric

July 27, 2015

Vidasym's phosphate binder VS-505 enters phase I/II trial

July 23, 2015

Gilead patents MAP3K5 inhibitors

July 20, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Biotle’s FcRn inhibitor BTL-203 cleared for clinic in China
BioWorld Science
Biotle has received a clinical trial notice from China’s National Medical Products Administration (NMPA) for its IND application for BTL-203, the company’s...